[go: up one dir, main page]

DE602005018369D1 - Neue proteine, z.b. zur verwendung für die in-vitro-isolierung und prävention von legionella pneumophila-infektionen - Google Patents

Neue proteine, z.b. zur verwendung für die in-vitro-isolierung und prävention von legionella pneumophila-infektionen

Info

Publication number
DE602005018369D1
DE602005018369D1 DE602005018369T DE602005018369T DE602005018369D1 DE 602005018369 D1 DE602005018369 D1 DE 602005018369D1 DE 602005018369 T DE602005018369 T DE 602005018369T DE 602005018369 T DE602005018369 T DE 602005018369T DE 602005018369 D1 DE602005018369 D1 DE 602005018369D1
Authority
DE
Germany
Prior art keywords
vitro
legionella pneumophila
prevention
insulation
polynucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005018369T
Other languages
English (en)
Inventor
Jean-Philippe Arie
Camille Cyncynatus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
InGen BioSciences
Universite Claude Bernard Lyon 1
Original Assignee
InGen BioSciences
Universite Claude Bernard Lyon 1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by InGen BioSciences, Universite Claude Bernard Lyon 1 filed Critical InGen BioSciences
Publication of DE602005018369D1 publication Critical patent/DE602005018369D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE602005018369T 2004-08-06 2005-06-21 Neue proteine, z.b. zur verwendung für die in-vitro-isolierung und prävention von legionella pneumophila-infektionen Expired - Lifetime DE602005018369D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0408714A FR2874025B1 (fr) 2004-08-06 2004-08-06 Nouvelles proteines permettant, notamment, la mise en evidence in vitro et la prevention des infections a legionella pneumophila
PCT/FR2005/001549 WO2006027431A1 (fr) 2004-08-06 2005-06-21 Nouvelles proteines permettant, notamment, la mise en evidence in vitro et la prevention des infections a legionella pneumophila

Publications (1)

Publication Number Publication Date
DE602005018369D1 true DE602005018369D1 (de) 2010-01-28

Family

ID=34949347

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005018369T Expired - Lifetime DE602005018369D1 (de) 2004-08-06 2005-06-21 Neue proteine, z.b. zur verwendung für die in-vitro-isolierung und prävention von legionella pneumophila-infektionen

Country Status (7)

Country Link
US (1) US7704697B2 (de)
EP (1) EP1781691B1 (de)
AT (1) ATE452141T1 (de)
CA (1) CA2576241A1 (de)
DE (1) DE602005018369D1 (de)
FR (1) FR2874025B1 (de)
WO (1) WO2006027431A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2895519B1 (fr) * 2005-12-28 2008-12-19 Abag Sa Utilisation de la proteine 5e2 dans le diagnostic in vitro d'infection a legionella pneumophila
FR2930646B1 (fr) * 2008-04-29 2012-09-07 Abag Detection, in vitro, d'anticorps produits a la suite d'une infection a legionella pneumophila
US8785145B2 (en) 2011-08-11 2014-07-22 Ingen Biosciences Method for diagnosing gram-negative infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
FR2862659B1 (fr) * 2003-11-21 2006-02-10 Pasteur Institut Genome de legionella pneumophila souche paris- applications diagnostiques et epidemiologiques

Also Published As

Publication number Publication date
US7704697B2 (en) 2010-04-27
US20080260767A1 (en) 2008-10-23
ATE452141T1 (de) 2010-01-15
FR2874025A1 (fr) 2006-02-10
CA2576241A1 (fr) 2006-03-16
FR2874025B1 (fr) 2006-10-27
WO2006027431A1 (fr) 2006-03-16
EP1781691A1 (de) 2007-05-09
EP1781691B1 (de) 2009-12-16

Similar Documents

Publication Publication Date Title
EA200901430A1 (ru) Варианты фермента аспарагиназы и их применение
MX348154B (es) Anticuerpos de enlace a il-1-beta y fragmentos de los mismos.
MX2011011215A (es) Polipeptido que degrada carbohidratos y usos del mismo.
ATE519842T1 (de) Trichoderma reesei-glucoamylase und homologe davon
IN2014CN02050A (de)
NZ595500A (en) Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them
NZ591415A (en) Haemophilus influenzae type B
MX2008009886A (es) Anticuerpos que enlazan par-2.
MX2009002816A (es) Proteinas de fusion de albumina.
EA201200398A1 (ru) Полипептиды с оксидоредуктазной активностью и их применение
TNSN08064A1 (en) Albumin fusion proteins
EA201690946A1 (ru) Мутанты fgf21 и их применение
DK1831362T3 (da) Syreaktive svampeproteaser
ATE417595T1 (de) Keratin-bindende polypeptide
TW201129379A (en) Anti-Orai1 antigen binding proteins and uses thereof
MY150226A (en) Novel h5 proteins, nucleic acid molecules and vectors encoding for those, and medicinal use
EA201300059A1 (ru) Полипептид, обладающий активностью сволленина, и его применение
WO2006097432A3 (de) Keratin-biktdende desmoplakinpolypeptidsequenzen
DE602005018369D1 (de) Neue proteine, z.b. zur verwendung für die in-vitro-isolierung und prävention von legionella pneumophila-infektionen
DK1913020T3 (da) Immunogene konstrukter
CY1111630T1 (el) Παραγωγα κυτοκινων
DE602005016417D1 (de) Neue polypeptide zur in-vintro-isolierung und vorbeugung von infektionen mit legionella pneumophila
WO2009083968A8 (en) Novel protein
KR20040053279A (ko) 스트레스 저항성 및 내성 단백질을 코딩하는 유전자
GB0409559D0 (en) Polypeptide

Legal Events

Date Code Title Description
8364 No opposition during term of opposition